Drug · DIN 00568627
VISKAZIDE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since September 20, 2025; first marketed December 31, 1983.
- Drug Identification Number (DIN)
- 00568627
- Company (DIN owner)
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pindolol and other diuretics C07CA03
- Class
- Human
- Record last updated
- October 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PINDOLOL | 10 MG | |
| HYDROCHLOROTHIAZIDE | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2021: NOC 25942New Drug Submission (NDS) · Change in product ownership
- May 30, 2018: NOC 20915New Drug Submission (NDS) · Merger - buyout
- August 14, 2015: NOC 17200New Drug Submission (NDS) · Transfer of drug identification numbers
- August 12, 1997: NOC 4026New Drug Submission (NDS)
Other DINs named VISKAZIDE
- DIN 00568635 · Dormant